# Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors

> **NCT00408655** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 38 (actual)

## Conditions studied

- Ovarian Sarcoma
- Ovarian Stromal Cancer
- Recurrent Endometrial Carcinoma
- Recurrent Ovarian Epithelial Cancer
- Recurrent Ovarian Germ Cell Tumor
- Stage III Endometrial Carcinoma
- Stage III Ovarian Epithelial Cancer
- Stage III Ovarian Germ Cell Tumor
- Stage IV Endometrial Carcinoma
- Stage IV Ovarian Epithelial Cancer
- Stage IV Ovarian Germ Cell Tumor
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** paclitaxel
- **DRUG:** carboplatin
- **DRUG:** temsirolimus

## Key facts

- **NCT ID:** NCT00408655
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2012-01
- **Final completion:** —
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2014-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00408655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00408655, "Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT00408655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*